Week in Review: Facebook’s Social Jobs App and XBRL Webinars

Posted by John E. Shave III | November 16, 2012

Facebook is introducing a new social jobs app, expanding its mission to connect people by joining job seekers with employers and recruiters. The service will feature more than 1.7 million jobs and is a move that Bloomberg characterized as a challenge to LinkedIn.

Also in tech news, XBRL US is hosting a series of webinars designed to further educate XBRL developers on technical aspects of XBRL and working with XBRL-formatted US GAAP data, and on business and funding opportunities for startups with XBRL-enabled tools. Our own Phil Moyer will lead the first webinar, “The VC Market and Opportunities for XBRL Applications.” Phil will also be a judge in the second annual XRBL Challenge.

Here’s what Safeguard and our partner companies have been busy with recently:

• Safeguard priced an offering of $50.5 million aggregate principal amount of its convertible senior debentures due 2018 in a private placement.
• Medivo launched a free mobile and web-based app for hereditary angioedema. In addition, the company appointed Dr. David B. Nash to its Medical Advisory Board, where he’ll help propel Medivo’s mission using more than 25 years of academic, research, and healthcare experience.
• NuPathe announced its third quarter 2012 results, highlighting the acceptance of its New Drug Application for Zecuity and the completion of its $28 million capital raise. In addition, NuPathe CEO Armando Anido presented a company overview at the 9th Annual Lazard Healthcare Conference.
• ThingWorx certified Libelium’s Internet of Things platform as ThingWorx-Ready, which will simplify Libelium’s creation and deployment of M2M solutions. TMCnet covered the news.

To read more of our Week in Review series, please use the following feed: safeguardscientifics.com/WeekInReview. Have a great weekend!

 

Tags: Conferences, Facebook, John E. Shave, Libelium, Medivo, Migraine, NuPathe, Phil Moyer, Technology, ThingWorx, Week in Review, XBRL US, Zecuity